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Aim: Little is known about the pattern of healthcare services for end-of-life patients 
with dementia (PwDs) in East Asia. We compared this pattern between PwDs and 
cancer patients in their last year of life in Taiwan. 
Methods: Taiwan’s National Health Insurance Research Database was applied for this 
case-control analysis. The records of patients who had dementia and died between 2002 
and 2011 were reviewed. The control group was decedents with cancer. The utilization 
of hospitalization, emergency department visits, and life-sustaining interventions during 
the last year of life between two groups were compared. 
Results: Of the 2724 patients enrolled, 908 had dementia and 1816 had cancer. PwDs 
were more likely to have higher frequency of admission to hospital and ICU and longer 
stays by comparing to cancer patients. PwDs had a higher risk of enteral tube insertion 
and feeding, endotracheal intubation and tracheostomy, mechanical ventilation, 
hemodialysis, and cardiopulmonary resuscitation (OR = 4.36, 95% CI = 3.51-5.41) the 
highest among selected procedures. 
Conclusions: PwDs in their last year of life in Taiwan underwent aggressive 
interventions significantly more frequently than did their counterparts in Western 
countries. Providing comfort-centered care for better quality-of-life for end-of-life 
PwDs is a priority of Taiwan’s national health policy. 
 




Dementia is a neurodegenerative illness and one of the major causes of disability 
and dependency among the elderly. Patients with dementia (PwDs) require a great deal 
of healthcare resources throughout the course of the disease.1 A 1-year follow-up study 
in Taiwan indicated s that PwDs had significantly more outpatient visits and 
hospitalization days than did those without dementia.2 
 In Western countries, comparisons of healthcare resource utilization between 
PwDs and cancer patients near the end of life are common because that these two 
diseases represent different illness trajectories.3,4 Previous studies, however, have 
documented various patterns. One study5 reported that, during the last month of life, 
PwDs in acute hospitals and long-term care facilities (LTCFs) are given less aggressive 
therapy than are patients without dementia. Other studies3,6 have shown that patients 
with advanced dementia commonly undergo more hospital transfers and burdensome 
interventions (e.g., tube feeding) than do patients with terminal cancer near the end of 
life. 
There are cross-cultural differences between Western and Asian countries that 
might influence medical professionals’ and caregivers’ attitudes toward terminally ill 
patients. One international study7 reported that one-third of Japanese physicians in 
intensive care units (ICUs) would not apply do-not-resuscitate (DNR) orders to patients 
with anoxic encephalopathy and in a vegetative state. When life-threatening events 
occurred in these vegetative patients, Japanese physicians chose aggressive 
interventions with continued full support, while physicians from Western countries 
would be more commonly withdraw life-sustaining treatments. Advanced dementia is 
generally not perceived as a terminal condition, and life preservation is the prevailing 
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value in Asian societies like China, India, Israel, and Japan.8-11 A lack of discussion 
about patients’ advance directives also causes a family’s surrogate decision-making to 
be the predominant factor of end-of-life management. Furthermore, palliative care, 
including opioids for symptom relief, might be limited for PwDs in the national 
healthcare systems in Asian countries.11 
Little is known about using aggressive medical treatments for PwDs and cancer 
patients near the end of their life in East Asia. We compared the utilization of healthcare 
services and life-sustaining interventions for PwDs and cancer patients in Taiwan in 
their last year before death. We hypothesized that PwDs undergo more aggressive 
procedures than those with cancer near the end of their life. 
 
Methods 
Data source and study population 
All data are from the Taiwan National Health Insurance Research Database 
(NHIRD). The NHI is a universal single-payer scheme that covers 99.9% of Taiwan’s 
legal residents. From the NHIRD, we obtained the Longitudinal Health Insurance 
Database (LHID2000), which contains all the original claims data of 1,000,000 
enrollees randomly sampled since 2000. Because the patient data are deidentified, the 
confidentiality of personal information in this database is assured, and using the data 
must be authorized by the Taiwan Bureau of National Health Insurance (BNHI). Our 
research protocol was approved by the institutional review board of Chi-Mei Medical 
Center. 
The study population included patients  18 years old who had been diagnosed 
with dementia and died during 2002-2011. Decedents with a diagnosis of dementia were 
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selected using the following criteria: (i) At least three outpatient service claims with the 
International Classification of Diseases, Ninth Revision, Clinical Modification 
(ICD-9-CM) codes of dementia (290.1x-209.4x, 291.2, 292.82, 294.1x, 294.8, 331.0, 
331.1x, 331.2, 331.82) at any clinic within one year after the first dementia code; (ii) 
any single hospitalization for dementia among the 5 principal claims diagnosis codes. 
We identified a control group of decedents with cancer who had catastrophic certificates 
with ICD-9-CM cancer codes: 140-208 (the detail was shown in Supplementary Table 
1). Patients who met the criteria for both dementia and cancer were excluded. 
Measurements 
We identified 1072 PwDs and 13,771 control patients who met the eligibility 
criteria. 908 PwDs were matched to two controls each (n=1816) by age and gender 
(N=2724). The characteristics among subjects excluded was shown in Supplementary 
Table 2. We measured the utilization of healthcare services during the last year of life 
between these two groups by comparing the frequency of hospital admissions, length of 
inpatient stays, emergency department (ED) visits, and non-palliative interventions 
(enteral tube insertion and feeding, blood transfusion, respiratory therapies, 
hemodialysis, and cardiopulmonary life-sustaining treatments). 
The comorbidities were also classified using ICD-9-CM codes: diabetes mellitus 
(250), cerebrovascular disease (CVD) (430-438), heart failure (428), chronic obstructive 
pulmonary disease (COPD) (491.2x, 492, 494, 496), liver cirrhosis (571.2, 571.5), renal 
failure (585.4-6, 586), and ischemic heart disease/coronary artery disease (CAD) 
(410-414). 
Statistical analysis 
Student's t test or the Wilcoxon rank-sum test for continuous variables, and 
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Pearson's 2 test for categorical variables were used to compare differences between 
patients who died of dementia and those who died of cancer. The association between 
matched cases and controls was measured using a conditional logistic regression model 
to calculate the odds ratios (ORs) and 95% confidence intervals (CIs). Significance was 




Characteristics of the study group 
We registered 2,724 decedents in this study. PwDs had a significantly (p < 0.001 
for all) higher proportion than did patients with cancer of diabetes, cerebrovascular 
disease, and renal failure before death (Table 1). 
Utilization of healthcare services 
In the last year before death, the most common causes of hospitalization and ED 
visits by dementia group were infectious diseases and their related complications (Table 
2). Chemotherapy was the major cause of hospitalization in the cancer group. After 
excluding the diagnoses related to cancer therapy, the common causes of hospitalization 
and ED visits in the cancer group were also infectious diseases. 
PwDs had higher proportion of ICU admissions than did cancer patients (odds ratio 
[OR] = 3.45; 95% confidence interval [CI] = 2.90-4.11) (Table 3). Among patients who 
had hospitalization, PwDs were more likely to have high frequency of admission to the 
hospital (OR = 1.26; 95% CI = 1.04-1.52) and ICU (OR = 2.01, 95% CI = 1.49-2.70), 
and to have longer hospital (OR = 1.40; 95% CI = 1.16-1.69) and ICU (OR = 1.92; 95% 




The prevalence of using life-sustaining treatments, except for blood transfusions, 
was significantly (p < 0.001) higher in PwDs (Table 4). After confounding covariates 
had been adjusted for, PwDs were more likely to undergo aggressive interventions. 
Cardiopulmonary resuscitation (CPR) had the highest risk (OR = 4.36; 95% CI = 
3.51-5.41). The use of CPR significantly increased within one month before death in 
two groups (Figure 1), and the frequency of CPR was more than 3 times higher for 
PwDs than for cancer patients. 
 
Discussion 
Our nationwide, population-based study found that, in Taiwan, PwDs in their last 
year of life are at a higher risk of undergoing aggressive life-sustaining interventions 
than are patients with cancer. To our knowledge, this is one of the pioneer nationwide 
investigations of healthcare utilization for PwDs near the end of life in East Asia. 
Comparison with international data 
Other studies have reported that burdensome hospitalizations had limited clinical 
benefits for cognitively impaired nursing-home residents. Gozalo et al.1 found that 19% 
of nursing-home residents had at least one burdensome transition near the end of life, 
and that 9.1% with advanced cognitive impairment were admitted to the ICU during 
their last 30 days of life. In Hong Kong, a longitudinal cohort study12 found that elderly 
patients with advanced cognitive impairment in LTCFs had a mean frequency of about 
3.1 ED visits and 2.7 acute hospital admissions during the 12 months of follow-up12. We 
found that 48.57% of PwDs in Taiwan had three or more acute hospital admissions and 
20.48% had two or more ICU admissions during their last year of life. 
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All the procedures of medical treatments, including feeding tube insertion for 
patients, whether they are admitted into acute hospitals or live in LTCFs, are reimbursed 
by the NHI in Taiwan. A retrospective study13 of LTCFs in Italy reported that 20.5% of 
PwDs were fed with a nasogastric (NG) tube or a percutaneous endoscopic gastrostomy 
(PEG) in their last 30 days of life. North American studies3,10 reported that 25% of 
patients in the US with advanced dementia were tube-fed near their end of life3, and that 
11% of patients in Canada with end-stage dementia were tube-fed in hospitals10. In Asia, 
66% of nursing-home residents in Hong Kong with advanced cognitive impairment 
were enterally fed in their last year of life12; whereas tube-feeding rate among patients 
with advanced dementia in Israel is 52.9%10. Compared with findings from international 
studies, the prevalence of tube feeding in the PwDs in our study (67.4%) significantly 
different from the rates in Europe and North America, and were higher than in most 
other Asian studies. The adjusted odds ratio of tube feeding between the PwD group and 
the cancer group in our study was 2.75, significantly higher than the 2.21 in a US 
study3. 
One retrospective US analysis5 reported that only 13% of its PwDs underwent 
mechanical ventilation and that 3.9% of them underwent hemodialysis in the last 30 
days of life, but in our survey, 61.45% of the PwDs underwent mechanical ventilation, 
and 17.62% underwent hemodialysis. The CPR rate in our dementia group (33.92%) 
was much higher than that in the data reported in an Italian study13 (2%). In the present 
study, the frequency of CPR near the end-of-life for PwDs was much higher than that 
for cancer patients, which implies that PwDs tend to continually undergo life-sustaining 
treatments when they are critically ill. Although the mortality rates of PwDs increase 
with the severity of cognitive impairment14, results of a large-scale population-based 
10 
 
cohort study15 across China, India, and Latin America showed that more than half of the 
mortality occurred in people with mild dementia at baseline, which means that, in our 
survey, resuscitation and additional treatments might have been done to reverse acute, 
unexpected physical conditions such as pneumonia and septicemia (see Supplementary 
Tables 3, 4), and to prevent mortality in PwDs, higher proportion of whom were 
probably in an mild or moderate rather than an advanced stage of dementia. However, 
the survival outcomes of these frail patients with prevalent comorbidities might not be 
as good as expected by medical professionals. In addition, aggressive interventions 
might be burdensome for patients and families. 
The discrepancy between our results in an Asian country and data from Western 
countries might be explained by the combination of culture, religion, administrative 
financial incentives, and the doctor-family-patient relationship8-11,16,17. An investigation9 
that explored different methods of caring for PwDs in the Netherlands and India 
reported that the PwDs themselves in India were rarely involved in deciding what kind 
of end-of-life care they should be given and underwent many aggressive treatments to 
prolong their life. PwDs were detected earlier in the Netherlands, and advance directives 
were more frequently established by patients, family, and healthcare professionals via a 
“dialogical” process, which led to less life-sustaining management in medically futile 
conditions. A study10 that compared tube-feeding for end-stage dementia across Canada 
and Israel reported that because of religion and culture, Israel’s administrative 
guidelines favored using NG tubes to save and extend life, which led to a huge gap in 
tube-feeding prevalences between Canada and Israel. 
Chinese culture, which is predominantly Confucian, is the main social context in 
Taiwan. Most of the Chinese elderly refrain from discussing death-related topics, which 
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makes advance end-of-life care planning difficult18. Even for PwDs who had expressed 
their preferences for end-of-life decisions, the proportion of discrepancy between 
patients and their caregivers was 48.3% for tube feeding, 48.5% for CPR, and 60.3% for 
mechanical ventilation in a Taiwanese investigation19. A majority of medical 
professionals and patients relied more on families’ preferences and physician authority 
than on patient autonomy17,18. Because it is a Chinese cultural belief that dying relatives 
become “hungry ghosts” if they are not supplied with artificial nutrition until they die20, 
and because the general public had insufficient understanding of life-sustaining 
treatments8, Chinese family caregivers are usually reluctant to prevent aggressive 
interventions. 
In contrast, one American study21 reported that using intensive procedures during 
the end of life was strongly affected by individual characteristics and regional practice 
patterns. NHI makes hospitalization and ICU care easily available to and affordable for 
almost everyone in Taiwan. The fee-for-service payment mechanisms in NHI schemes 
in Taiwan might be incentives for the overutilization of medical services here, 
however22. Furthermore, medical dispute cases in Taiwan have significantly increased 
over the past two decades. Almost 80% are criminal suits, which might cause medical 
professionals to practice defensive medicine by doing additional and aggressive 
life-prolonging interventions even for patients with poor prognoses23. 
Benefits and barriers of giving PwDs comfort-centered care 
Several studies24-26 have shown that palliative care improved the quality of 
end-of-life care and increased patient satisfaction, and reduced, for cancer and 
non-cancer patients, the use of aggressive medical services: ICU admission, artificial 
nutrition, and artificial hydration. One American study27 reported that interviewed 
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bereaved family members of deceased PwDs said that hospice services improved their 
perceptions of the quality of care for the patients and the quality of the dying 
experience27. However, providing hospice services to PwDs is still limited in Taiwan: 
less than 0.1% of all patients were given in-patient hospice services in 201328. 
There might be some barriers for giving palliative care to PwDs near the end of life. 
First, advanced dementia is not normally considered a progressively terminal illness by 
the general population or medical professionals in many Asian countries8-11,29. Second, 
the “dying trajectories” of cancer and dementia are quite different. While the gradual 
deterioration of people with dementia for a longer time is recognized, the trajectory 
might be cut short by death after an unexpected acute illness like pneumonia3,4,15. It is 
challenging to accurately estimate life expectancy in advanced dementia and provide 
timely palliative care based on a paradigm of survival prediction30. Early discussion of 
care planning with the PwDs and their family members about acceptable life-sustaining 
measures is urgently needed19,21.  
Neurologists are the main specialists for treating PwDs in Taiwan. Internal 
medicine physicians, however, usually take the major responsibility for inpatient care of 
PwDs in their late stage of life. The clinical interpretation, therefore, suggests that both 
neurologists and internists should upgrade their knowledge and skills for providing 
comfort-oriented care, and for helping PwDs and their relatives make decisions in the 
patients’ best interests. 
Strengths and limitations 
The strengths of the present study include its long period of case registration, its 
age- and gender-matched compared groups, and its using a nationwide database. 
Dementia is a major health economic priority worldwide, yet the evidence base is small. 
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The present study provides a nationwide pattern of clinical practice. 
The limitations are that the study was done only in Taiwan, a small country in Asia, 
which limits its generalizability to other areas. Taiwan’s cultural values about disease 
awareness and treatment choice, however, are strongly influenced by Chinese and 
Japanese values, so that our results gave possible hints about the condition in other 
nearby Asian countries. Second, the limitation of major diagnostic codes can be 
identified in outpatient service claims, and insufficient awareness among healthcare 
professionals in hospitals of coding dementia as a crucial underlying disease for patients, 
might have caused us to underestimate the prevalence of dementia in our 
population-based study. Another limitation is that the atypical presentation of diseases in 
the elderly and under-reported symptoms both contribute to an underestimation of 
cancer in PwDs, which lead to a possible selection bias. Finally, the severity of disease 
cannot be identified and classified because the NHIRD does not provide that 
information. 
The noteworthy high risk of PwDs undergoing life-sustaining treatments in their 
last year of life, regardless of the level of their cognitive impairment, indicates that they 
are not be given sufficient palliative care. A national health policy that endorses 
palliative care for PwDs near the end of life and continuous end-of-life care education 
for multidisciplinary medical professionals should be advocated. Additional studies are 
needed to better understand the mechanisms and key determinants underlying the use of 
life-sustaining treatments in patients with different levels of dementia, and to evaluate 
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Figure 1. Frequency of cardiopulmonary resuscitation in the dementia group and the 
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Table 1. Demographic characteristics of the study participants: patients with dementia 
and patients with cancer (N = 2724) 
 
Group: Dementia Cancer  
Variables (n = 908) (n = 1816) p-value 
Age at death, mean ± SD 77.12 ± 11.26 77.12 ± 11.25 0.9936 
Age at death, n (%)    
< 50 34 (3.74) 68 (3.74) 1.0000 
50-65 70 (7.71) 141 (7.76)  
65-80 374 (41.19) 747 (41.13)  
 80 430 (47.36) 860 (47.36)  
Gender, n (%)    
Male 522 (57.49) 1044 (57.49) 1.0000 
Comorbidities, n (%)    
Diabetes 274 (30.18) 421 (23.18) < 0.001 
Cerebrovascular disease 358 (39.43) 280 (15.42) < 0.001 
Heart failure 97 (10.68) 156 (8.59) 0.0761 
Chronic obstructive pulmonary disease 152 (16.74) 283 (15.58) 0.4373 
Liver cirrhosis 28 (3.08) 123 (6.77) < 0.001 
Renal failure 41 (4.52) 31 (1.71) < 0.001 
Coronary artery disease 167 (18.39) 384 (21.15) 0.0917 
SD = standard deviation. 
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Table 2. Common causes of hospitalization and emergency department visits in the last 
year of life by patients with dementia and patients with cancer 
 Group: Dementia  Cancer 
Rank Diagnosis n (%) † Diagnosis† n (%) 






2 Acute respiratory failure 
515 
(12.22) 
Sepsis 168 (2.11) 
3 Urinary tract infection 193 (4.58) Urinary tract infection 167 (2.10) 





Obstructive chronic bronchitis 
with acute exacerbation 
146 (3.46) Fever 117 (1.47) 
6 Chronic renal failure 122 (2.90) Liver cirrhosis 96(1.21) 












10 Non-alcoholic liver cirrhosis 61 (1.45) Hepatic coma 51(0.64) 
† The diagnosis of chemotherapy and specific cancers such as lung cancer, liver cancer 
or gastric cancer were not shown. 
‡ The total diagnosed frequency was 4214 for patients with dementia and 7953 for 
patients with cancer. 
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Table 3. Utilization of hospitalization and emergency department services in the last 
year of life of decedents with dementia and decedents with cancer 
 
 Dementia 
(n = 908) 
Cancer 
(n = 1816) 
p-value Adjusted odds 
ratio † 
(95% CI)     
Patients visited ED, n (%) 456 (50.22) 977 (53.80) 0.0778 0.87(0.73-1.02) 
Frequency of ED visits per 
person, n (%) 
    
< 3 times 287(62.94) 613(62.74) 0.9431 1.00(ref.) 
≥ 3 times 169(37.06) 364(37.26)  0.90(0.70-1.15) 
Patients had acute hospital 
care, n (%) 
748 (82.38) 1471(81.00) 0.3834 1.14(0.91-1.41) 
  Frequency of 
hospitalization per person, n 
(%) 
    
< 3 times 307(41.04) 1047(47.72) 0.0028 1.00(ref.) 
≥ 3 times 441(58.96) 769(52.28)  1.26(1.04-1.52) 
  Length of stay per person, n 
(%) 
    
< 30 days 299(39.97) 1079(49.90) <.0001 1.00(ref.) 
>= 30 days 449(60.03) 737(50.10)  1.40(1.16-1.69) 
Patients had ICU admission, n 
(%) 
538 (59.25) 519 (28.58) < .0001 3.45(2.90-4.11) 
Frequency of ICU admissi
on per person, n (%) 
   
 
< 2 times 352(65.43) 419(80.73) <.0001 1.00(ref.) 
≥ 2 times 186(34.57) 100(19.27)  2.01(1.49-2.70) 
Length of stay per person,
 n (%) 
   
 
< 3 days 376(69.89) 430(82.85) <.0001 1.00(ref.) 
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≥ 3 days 162(30.11) 89(17.15)  1.92(1.41-2.61) 
Doctors in charge of patients’ 
care during hospitalization 
    
Neurologists, n (%) 88 (9.69) 37 (2.04) < .0001 4.24(2.81-6.39) 
Internal medicine physician
s, n (%) 
451 (49.67) 657 (36.18) < .0001 1.85(1.56-2.19) 
Surgeons‡, n (%) 129 (14.21) 322 (17.73) 0.0197 0.81(0.64-1.03) 
Orthopedic surgeons, n 
(%) 
47 (5.18) 43 (2.37) < .0001 2.46(1.59-3.81) 
CI = confidence interval; ED = emergency department; ICU = intensive care unit. 
† Adjusted for confounding covariates, including comorbidities. 
‡ Excluding orthopedic surgeons. 
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Table 4. Analysis of use of life-sustaining treatments in the last year of life between 






p-value Adjusted odds 
ratio† 
(95% CI) 
Enteral tube insertion‡, n (%) 659(72.58) 878(48.35) <.0001 2.63(2.20-3.14) 
Tube feeding, n (%) 612(67.40) 741(40.80) <.0001 2.75(2.31-3.27) 
Blood transfusion§, n (%) 524(57.71) 979(53.91) 0.0601 1.11(0.94-1.32) 
Respiratory therapies     
Mechanical ventilation and 
HFOV
 ¶, n (%) 
558(61.45) 481(26.49) <.0001 4.11(3.45-4.91) 
Noninvasive positive pressure 




Endotracheal intubation, n 
(%) 
536(59.03) 435(23.95) <.0001 4.23(3.54-5.05) 
Tracheostomy, n (%) 89(9.80) 55(3.03) <.0001 3.23(2.25-4.64) 
Hemodialysis, n (%) 160(17.62) 96(5.29) <.0001 3.26(2.42-4.40) 
Cardiopulmonary 
life-sustaining treatments  
    
Defibrillation and Temporary 
pacemaker, n (%) 
93(10.24) 46(2.53) <.0001 3.81(2.60-5.57) 
Cardiopulmonary 
resuscitation, n (%) 
308(33.92) 183(10.08) <.0001 4.36(3.51-5.41) 
CI = confidence interval. 
† Adjusted for confounding covariates, including comorbidities. 
‡ Included nasogastric tube insertions, gastrostomy, jejunostomy. 
§ Whole blood, packed red blood cell transfusion. 
¶ HFOV (High Frequency Oscillatory Ventilation). 
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\\ Included Nasal PAP (Nasal Positive Airway Pressure), CPAP (Continuous Positive 
Airway Pressure), Bi-PAP (Bi-level Positive Airway Pressure). 
